Implementing Low-dose ct Lung Cancer Screening in France.
Recruiting · NCT07513818 · Interventional (participants receive a specific treatment) · Lead sponsor: Assistance Publique - Hôpitaux de Paris
View the official record on ClinicalTrials.gov →Interventions studied
Low-dose computed tomography of the chest
What this trial is about
The main objective is to estimate the detection rate of lung cancer in the population screened by low-dose chest CT scans.
Who can take part
Age range
50 Years to 74 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Adults aged 50-74 years
- Active or former smoker having quit less than 15 years ago
- Smoking history of at least 20 pack-years, or 15 cigarettes/day for 25 years or 10 cigarettes/day for 30 years
- Affiliation with a social security scheme
- Written informed consent prior to study participation
- Temporary
Exclusion criteria
- Chest CT scan performed within the previous 12 months
- Signs of respiratory infection (fever, productive cough)
- Exclusion Criteria:
- Severe co-morbidities contraindicating exploration and/or management (including stereotactic surgery or radiotherapy) of lung cancers
- Poor general status (PS2 and above)
- Rest dyspnea (mMRC4)
- Cancer under active surveillance by thoracic computed tomography (CT pr PET-CT)
- Personal history of lung cancer
- Symptoms raising suspicion of lung cancer (hemoptysis, unexplained weight loss, recent onset or modification of respiratory symptoms,…)
Where it is running
2 locations listed.
- HCL - Hôpital Lyon Sud - Lyon, France, France
- Hôpital Cochin - Paris, Île-de-France Region, France